We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
LECO and Genedata Collaborate on Mass Spectrometry Data Analysis
News

LECO and Genedata Collaborate on Mass Spectrometry Data Analysis

LECO and Genedata Collaborate on Mass Spectrometry Data Analysis
News

LECO and Genedata Collaborate on Mass Spectrometry Data Analysis

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "LECO and Genedata Collaborate on Mass Spectrometry Data Analysis"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Genedata and LECO have announced their collaboration, which brings to market Genedata Expressionist® MSX software compatibility with LECO High Resolution TOFMS (HRT) instrumentation.

Designed for complex sample analysis, LECO’s HRT technology provides acquisition speeds of up to 200 spectra/second, mass resolution up to 100,000 FWHM, and mass accuracy less than 1 ppm.

Genedata Expressionist MSX is a comprehensive, end-to-end solution for the analysis of mass spectrometry data generated in metabolomics experiments.

“For LECO customers, it will be a great advantage to be able to utilize Expressionist MSX, together with our HRT platform, in their metabolomics applications,” said Dr. Jeff Patrick, director of Marketed Technology, LECO Separation Science.

Dr. Patrick continued, “We understand the unique challenges of metabolomics, and we are proud to provide instrumentation with the speed, sensitivity, resolution, and data-handling tools necessary to meet these challenges head-on. We look forward to a continued collaboration with Genedata that will effectively leverage our mutual capabilities.”

“With the ability to efficiently process raw MS data from LECO instrumentation, Expressionist MSX will enable scientists to quickly address a wide range of metabolomics questions, capitalizing on the high-performance of HRT output,” noted Dr. Othmar Pfannes, CEO of Genedata.

Dr. Pfannes continued, “Our collaboration with LECO empowers researchers and advances innovative discovery in pharmaceutical, industrial biotechnology, and life science companies.”

Advertisement